Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

2021 Annual Report now published

Investor AB has today published the Annual Report 2021 including the Sustainability Report, on www.investorab.com. 2021 was characterized by the covid-19 pandemic, but also by economic recovery and rallying equity markets, making it a strong year for Investor. In the Annual Report, Jacob Wallenberg Investor’s Chair of the Board, and Johan Forssell Investors’ CEO comments on the situation in Ukraine. “Tragically, 2022 will forever be remembered for the unprovoked Russian invasion and war in Ukraine, the first major war in Europe in over 80 years. Regardless of how this tragedy

Notice of Investor AB’s Annual General Meeting on May 3, 2022

Investor AB (publ) summons to the Annual General Meeting (the “Meeting”) to be held on Tuesday, May 3, 2022, at 3:00 p.m. at City Conference Centre, Barnhusgatan 12-14, Stockholm, Sweden. Registration for the Meeting will commence at 1:30 p.m. The “Investor Dialog” begins at 2:00 p.m. – a dialogue between Investor’s Chair of the Board, Jacob Wallenberg, Investor’s President, Johan Forssell, and our shareholders. The shareholders will also have the opportunity to exercise their voting rights by advance voting prior to the Meeting. The Meeting and the Investor Dialog can be followed online

The Nomination Committee’s proposal for election of members of the Board of Directors of Investor AB

The Nomination Committee of Investor AB submits the following proposals for resolution at the Annual General Meeting of shareholders on May 3, 2022, with regard to the number and election of members of the Board of Directors. The Nomination Committee proposes eleven members of the Board of Directors and no deputy members of the Board of Directors. The Nomination Committee proposes the following persons for re-election as members of the Board of Directors: Gunnar Brock, Johan Forssell, Magdalena Gerger, Tom Johnstone, Isabelle Kocher, Sven Nyman, Grace Reksten Skaugen, Hans Stråberg,

New Members of Rikshem Board of Directors

At the Annual General Meeting on 24 March 2022, Siv Malmgren and Zdravko Markovski were elected as new ordinary members of the Board of Directors of Rikshem AB (publ)s.The election of the new board members means that Rikshem's board has expanded from six to eight ordinary members. Siv Malmgren Siv Malmgren was born in 1959 and holds a PhD in Behavioural Science and an MBA from Stockholm University. She has previously been CEO of John Mattson and a board member of Willhem, Fastighetsägarna Stockholm, Fastighetsägarna Sverige and Handelsbanken, Regionbank Stockholm. Zdravko Markovski

Faron´s Annual Report 2021 Published

Faron Pharmaceuticals Ltd (“Faron” or the “Company”)   Faron´s Annual Report 2021 Published     Company announcement, 25 March 2022 at 9.15 AM (EET) / 07:15 AM (GMT) / 03:15 AM (EDT)    TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, announces that its Annual Report for the year 2021 has been published today.   Faron Pharmaceuticals´ Annual Report

Keliber’s Lithium Project value increases by 220% to EUR 1.2 billion in Updated Definitive Feasibility Study

Keliber has today released the Updated Definitive Feasibility Study (“UDFS”) for the Lithium Project in Central Ostrobothnia, Finland. The updated Definitive Feasibility Study to produce battery-grade lithium hydroxide (LiOH) confirms a solid financial and technical feasibility of the project, with significant improvements in the key financials compared to the Definitive Feasibility Study (“DFS”) from 2019. Key Figures Unit UDFS2022 DFS2019FinancialPost-tax NPV (8% real EUR million 1,228 384discount rate)Post-tax internal rate of %

ABS – Share Capital Increase Registered

Reference is made to the stock exchange release published by Arctic Bioscience 23 February 2022 regarding Board approval of share capital increase related to the exercise of share options and corresponding issuance of new shares in Arctic Bioscience.The share capital increase has now been registered with the Norwegian Register of Business Enterprises.  As a result, the new share capital of Arctic Bioscience has increased from 2,429,953.90 to 2,437,571.90, divided into 24,375,719 shares, each having a nominal value of NOK 0.10.

Recently Updated Definitive Feasibility Study Shows Keliber’s Strong Profitability

Keliber has finalised its work to update the Definitive Feasibility Study (updated DFS). The updated DFS to produce battery-grade lithium hydroxide (LiOH) confirms a solid financial and technical feasibility of the project. Key Figures Unit DFS Value 2022FinancialTotal project capital expenditure EUR million 475Post-tax NPV (8% discount rate) EUR million 1,228Post-tax Internal Rate of Return % 31(IRR)Payback Period (from the start of Years 3.5production)

Aker Solutions Names Kjerstin Kleyne Braaten as SVP Aquaculture

March 25, 2022 - Aker Solutions has hired Kjerstin Kleyne Braaten as senior vice president of aquaculture, which is one of the growth areas for the company. Braaten has broad industry experience and will cooperate closely with potential customers and other partners to develop new solutions for the large projects which are expected to be sanctioned in the future. For many years, Aker Solutions has been one of the world’s leading suppliers of complete facilities for oil and gas production. The company is increasingly involved in the development and delivery of solutions for

Notification of Catena’s 2022 Annual General Meeting

Shareholders of Catena AB (publ) are hereby invited to attend the Annual General Meeting on 28 April 2022 16:00 CEST, at World Trade Center, Klarabergsviadukten 70 in Stockholm, Sweden.25 March 2022 8:00 a.m A shareholder who wishes to participate in the Annual General Meeting must (i) be included as a shareholder in the share register maintained by Euroclear Sweden AB regarding the status on 20 April 2022 and (ii) notify the Company of their and eventual proxies intention to attend the Annual General Meeting on 22 April 2022 at the latest via the Company webpage www.catenafastigheter.se.

Notice of the annual general meeting 2022

The shareholders of Careium AB (publ), Reg. No. 559121–5875 (the Company), are hereby notified of the annual general meeting on Thursday, April 29, 2022. The Annual General Meeting will, with the support of temporary legal rules, be conducted in accordance with mail-in procedures, meaning that no shareholders will attend the AGM in person or through proxy. Instead, shareholders can participate in the AGM by voting and submitting questions in advance pursuant to the instructions described below.RIGHT TO ATTEND Shareholders who are registered in the register of shareholders maintained by

Dividend amount in XACT Sverige (UCITS ETF)

The dividend amount of the above stated Exchange Traded Fund is SEK 27.43 per fund unit. Registered holder of fund units on the record day will receive dividend.   The schedule for the dividend is as follows: June 13         Last day to trade fund units including the right to receive dividend June 14         Ex-dividend; the fund units are traded ex dividend June 15         Record day June 20         Payment day The above applies unless otherwise published. For further information, please contact:   Magdalena Wahlqvist Alveskog, CEO Handelsbanken Fonder AB:  +46 (

Annual General Meeting in Alimak Group

The Board of Alimak Group AB has resolved to convene an Annual General Meeting to be held on May 5, 2022. More detailed information about the contents of the proposals may be obtained from the complete notice to the annual general meeting below.The notice will be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the Company’s website within the next few days. NOTICE OF ANNUAL GENERAL MEETING IN ALIMAK GROUP AB (PUBL) The Annual General Meeting of Alimak Group AB (publ) will be held on Thursday, May 5, 2022 at 4:00 pm at Klara Strand, S:ta Clara,

Brain+ selected as ‘digital showcase for Denmark’ by Digital Hub Denmark

Brain+ has been selected as showcase in the HealthTech category, among other top cutting-edge start-ups from Denmark, who are leading the digital transformation of society. The selection of Brain+ is motivated by the company’s achievements and commitment to make effective dementia and Alzheimer’s treatments available to everyone, as digital medicine.Denmark is the world champion in digitalization. Combining a rising startup scene, record-breaking investment activity and world-leading research, Denmark is looked to internationally as a source of inspiration and as the place to find high-

DDM Debt AB publishes its 2021 Annual report

DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) ("DDM Debt") today published its 2021 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch . A printed copy can be ordered via the website or by mail: investor@ddm-group.ch DDM Debt currently intends to publish financial information on the following dates in 2022: Interim report January – March 2022: 5 May 2022Annual General Meeting 2022: 23 June 2022Interim report January – June 2022: 28 July 2022Interim report January –

Financial Statement January 1 to December 31 2021

Faron Pharmaceuticals Ltd. (“Faron” or “Company”)   Faron Financial Statement Release January 1 to December 31, 2021   Financial statement release March 25, 2022 at 09:00 AM (EET) / 07:00 AM (GMT) / 03:00 AM (EDT)  Inside information   2021 Highlights · Bexmarilimab shows compelling antitumor activity in multiple advanced treatment resistant solid tumor types as a monotherapy with strongest clinical benefit rate (partial response or stable disease) observed in five different tumor types – cutaneous melanoma (30%), gastric cancer (30%), cholangiocarcinoma (30%),

The last day for trading in Moberg Pharma's warrants of series 2020:1 is today, 25 March 2022

STOCKHOLM, March 25[th], 2022. Today, 25 March 2022, is the last day for trading in Moberg Pharma AB's (publ)'s ("Moberg Pharma" or the "Company") warrants of series 2020:1. The exercise period runs until 29 March 2022.In 2020, Moberg Pharma carried out a rights issue of units. Each unit consisted of one (1) ordinary share and one (1) warrant in Moberg Pharma. Two (2) warrants entitle the holder to subscribe for one (1) new ordinary share in Moberg Pharma. The subscription price is SEK 6.47. Warrants of series 2020:1 in briefExercise period: 16 March 2022 - 29 March 2022.

HOYNG ROKH MONEGIER chooses Proact as IT partner for workspace and infrastructure solutions

As an international intellectual property law firm with offices throughout Europe, HOYNG ROKH MONEGIER (HRM) relies on the ability to offer efficient, modern workspaces for their employees. It is business-critical that employees have access to applications and data from anywhere, as they often work at their customers’ locations. HRM recently partnered with IT services provider Proact for support with these modern workspace and infrastructure needs.HRM’s entire IT environment is located in the cloud, including its data storage. In addition, the law firm also uses Azure and Microsoft 365.

Orkla’s Annual Report now published

Orkla’s Annual Report for 2021, which also includes its Sustainability Report, has been published today.As stated in the Annual Report, operating revenues increased by 7.0% to NOK 50,441 million in 2021. Operating profit EBIT (adj.) rose 11.9% in 2021 to NOK 6,145 million.  In 2021, earnings per share (adjusted) amounted to NOK 5.17, an increase of 2.6%. Orkla’s Board of Directors will propose to the General Meeting that the dividend for the 2021 financial year be increased by 25 øre to NOK 3.00 per share. As at 31 December 2021, the Group had 21,423 employees and 114 factories in 22

Notice to attend the Annual General Meeting of Serneke Group AB (publ)

Shareholders of Serneke Group AB (publ) (“Serneke”) or (“the Company”), corporate identity number 556669-4153, are hereby invited to the Annual General Meeting Tuesday 26 May at 2:00 p.m. (CET) at the Company's premises at Kvarnbergsgatan 2 in Gothenburg.REGISTRATION – RIGHT TO PARTICIPATEShareholders wishing to take part in Annual General Meeting must be registered in the shareholders’ register maintained by Euroclear Sweden AB as of Thursday 14 April 2022, and have notified the Company of their participation, no later than Wednesday 20 April 2022, preferably before 4:00 p.m. (CET).

Haldex publishes Annual and Sustainability Report 2021

Haldex AB (publ) today announces that the annual report and sustainability report for 2021 has been published and is available in both Swedish and English. The report describes how Haldex creates value for shareholders, employees, customers, and society. A digital version can be downloaded at https://www.haldex.com/en/corporate/investors/financial-reports/. A printed copy can be ordered by calling the switchboard on tel. +46 418 47 60 00 or by sending an email to ir@haldex.com. The printed copies are expected to be ready for distribution during week 16. The annual report is published in

DDM Holding AG publishes its 2021 Annual report

DDM Holding AG (First North Growth Market: DDM) today published its 2021 Annual report. The document is available on the DDM Group's website, www.ddm-group.ch . A printed copy can be ordered via the website or by mail: investor@ddm-group.ch DDM currently intends to publish financial information on the following dates in 2022: Interim report January – March 2022: 5 May 2022Annual General Meeting 2022: 23 June 2022Interim report January – June 2022: 28 July 2022Interim report January – September 2022: 3

Notice to the Annual General Meeting

Kamux Corporation     Stock Exchange Release                    25 March 2022 at 9.00 a.m. (EET) Notice to the Annual General Meeting Notice is given to the shareholders of Kamux Corporation to the Annual General Meeting held on Wednesday 20 April 2022 at 10 a.m. The AGM will be held under extraordinary meeting procedures without shareholders’ or their proxy representatives’ presence at Hotel Kämp’s Symposion meeting venue, Pohjoisesplanadi 29, 00100 Helsinki. The Board of Directors of the company has resolved on exceptional meeting procedures based on the so-called temporary act (

Tele2 expects to complete the divestment of T-Mobile Netherlands in the coming weeks

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) expects to complete the divestment of T-Mobile Netherlands in the coming weeks. Tele2’s Board of Directors proposes that the full cash proceeds should be distributed to the shareholders of Tele2 through an extraordinary dividend of SEK 13.00 per share, pending receival of the cash proceeds.On September 7 2021, Tele2 announced that Tele2 and Deutsche Telekom had agreed to sell their 25% and 75% stakes, respectively, in T-Mobile Netherlands to funds advised by Apax Partners LLP and Warburg Pincus LLC for an enterprise value

There are no items matching the current filter
There are no more items matching the current filter
Back to top